The incidence of gene mutations and EVI1 overexpression in the whole cohort and in the subset of CN-AML are respectively indicated in Table 2, and Tables S1 and S2 in the Supplementary Data. The gene discussed is RUNX1; the disease is acute myeloid leukemia.